News

AARDEX group will be at the 42th Annual Conference of the German Society of Hypertension

NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 42th Annual Conference

AARDEX Group will be at the 2nd value added medicines conference 2018

NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines

AARDEX Group will be at ESPACOMP 2018

OCT-2018 : AARDEX Group will be at ESPACOMP 2018 from November 29th to December

AARDEX group will be at the Annual Meeting of the American College of Rheumatology

OCT-2018 : AARDEX group will speak at the Annual Meeting of the American College of Rheumatology

AARDEX Group will be at ISPOR Europe.

OCT-2018 : AARDEX Group will be at ISPOR Europe in Barcelona 10-14 November 2018.

New MEMS® 8 technology, the precision of a Swiss watch

AUG-2018 : The new MEMS® 8 technology has a precision comparable

Major contributions of AARDEX Group to HIV medication adherence monitoring and management

AUG-2018 : Amsterdam, 22nd International AIDS Conference: AARDEX Group presented

OECD confirms that investing in medication adherence improves health outcomes and health system efficiency

AUG-2018 : In this groundbreaking publication, the OECD discusses the importance of medication

Important NIH Funding Opportunity

JUL-2018 : The National Institutes of Health (NIH) qualified medication adherence